Brief: C4 Therapeutics Q1 EPS USD -0.2 Vs. IBES Estimate USD -0.37
12/05/2026 12:00
May 12 (Reuters) - C4 Therapeutics Q1 revenue USD 6.2 million vs. IBES estimate USD 3.33 million.
CCCC — C4 Therapeutics News Story
0.000.00%
Last trade - 00:00- $391.22m
- $137.56m
- $35.95m